Duration of lead time in screening for lung cancer

BACKGROUND: Screening for lung cancer has used chest radiography (CR), low dose computed tomography (LDCT) and sputum cytology (SC). Estimates of the lead time (LT), i.e., the time interval from detection of lung cancer by screening to the development of symptoms, have been derived from longitudinal...

Descripción completa

Detalles Bibliográficos
Autor principal: Benbassat, Jochanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788818/
https://www.ncbi.nlm.nih.gov/pubmed/33407288
http://dx.doi.org/10.1186/s12890-020-01385-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788818/
https://www.ncbi.nlm.nih.gov/pubmed/33407288
http://dx.doi.org/10.1186/s12890-020-01385-3

Ejemplares similares